Giuseppe Cabibbo MD, PhD
Giuseppe Cabibbo MD, PhD
Verified email at unipa.it - Homepage
TitleCited byYear
A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
G Cabibbo, M Enea, M Attanasio, J Bruix, A Craxė, C Cammā
Hepatology 51 (4), 1274-1283, 2010
3022010
Field‐practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ...
Hepatology, 2011
3012011
Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease
F Bortolotti, G Verucchi, C Cammā, G Cabibbo, L Zancan, G Indolfi, ...
Gastroenterology 134 (7), 1900-1907, 2008
231*2008
The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data
F Fiorica, F Cartei, M Enea, A Licata, G Cabibbo, B Carau, A Liboni, ...
Cancer treatment reviews 33 (8), 729-740, 2007
1342007
Epidemiology, risk factors and surveillance of hepatocellular carcinoma
G Cabibbo, A Craxi
Eur Rev Med Pharmacol Sci 14 (4), 352-355, 2010
1142010
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study
C Camma, V Di Marco, A Orlando, L Sandonato, A Casaril, P Parisi, ...
Journal of hepatology 42 (4), 535-540, 2005
113*2005
Natural history of untreatable hepatocellular carcinoma: a retrospective cohort study
G Cabibbo, M Maida, C Genco, P Parisi, M Peralta, M Antonucci, ...
World journal of hepatology 4 (9), 256, 2012
109*2012
Multimodal approaches to the treatment of hepatocellular carcinoma
G Cabibbo, F Latteri, M Antonucci, A Craxė
Nature Reviews Gastroenterology & Hepatology 6 (3), 159, 2009
912009
Cost‐effectiveness of sofosbuvir‐based triple therapy for untreated patients with genotype 1 chronic hepatitis C
S Petta, G Cabibbo, M Enea, FS Macaluso, A Plaia, R Bruno, A Gasbarrini, ...
Hepatology 59 (5), 1692-1705, 2014
892014
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study
A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ...
Journal of hepatology 62 (3), 617-624, 2015
882015
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems
C Cammā, VD Marco, G Cabibbo, F Latteri, L Sandonato, P Parisi, ...
Alimentary pharmacology & therapeutics 28 (1), 62-75, 2008
882008
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study
E Villa, R Critelli, B Lei, G Marzocchi, C Cammā, G Giannelli, P Pontisso, ...
Gut 65 (5), 861-869, 2016
862016
Quality of ulcer healing in gastrointestinal tract: its pathophysiology and clinical relevance
T Arakawa, T Watanabe, T Tanigawa, K Tominaga, Y Fujiwara, ...
World Journal of Gastroenterology: WJG 18 (35), 4811, 2012
84*2012
Effects of eradicating hepatitis C virus infection in patients with cirrhosis differ with stage of portal hypertension
V Di Marco, V Calvaruso, D Ferraro, MG Bavetta, G Cabibbo, E Conte, ...
Gastroenterology 151 (1), 130-139. e2, 2016
812016
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population
S Bruno, V Di Marco, M Iavarone, L Roffi, A Crosignani, V Calvaruso, ...
Journal of hepatology 64 (6), 1217-1223, 2016
812016
Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease
S Renna, C Cammā, I Modesto, G Cabibbo, D Scimeca, G Civitavecchia, ...
Gastroenterology 135 (5), 1500-1509, 2008
812008
Cost‐effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma
C Cammā, G Cabibbo, S Petta, M Enea, M Iavarone, A Grieco, ...
Hepatology 57 (3), 1046-1054, 2013
802013
Staging systems of hepatocellular carcinoma: a review of literature
M Maida, E Orlando, C Cammā, G Cabibbo
World Journal of Gastroenterology: WJG 20 (15), 4141, 2014
772014
Direct antiviral agents and risk for HCC early recurrence: much ado about nothing
C Cammā, G Cabibbo, A Craxė
Journal of hepatology 65 (4), 861-862, 2016
762016
Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib
M Iavarone, G Cabibbo, M Biolato, C Della Corte, M Maida, M Barbara, ...
Hepatology 62 (3), 784-791, 2015
732015
The system can't perform the operation now. Try again later.
Articles 1–20